怀孕期间的胆摄入会影响母亲的认知功能和成年后期的海马基因表达
Qian Yee Woo1, Bernett T K Lee2, Lee Wei Lim3
1School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Nutritional neuroscience
|August 25, 2025
概括
在怀孕期间摄入足够的胆对于认知健康至关重要. 补充剂可以在怀孕期间和晚年改善认知能力,从而降低女性痴呆风险.
科学领域:
- 神经科学
- 营养科学
- 基因组学
背景情况:
- 女性患阿尔茨海默病的风险高于男性.
- 多种性是痴呆的潜在危险因素.
- 怀孕期间的营养缺乏可能会影响母亲和后代的认知能力.
研究的目的:
- 研究孕期营养素对认知功能的影响.
- 评估胆摄入对怀孕期间和成年后期认知的影响.
- 探索产前胆固醇对海马基因表达的长期影响.
主要方法:
- 用小鼠模型来评估怀孕和衰老中的认知功能.
- 非向性NMR分析发现了血代谢物的变化.
- 行为测试 (新型物体识别,莫里斯水迷宫) 评估认知能力.
- 在15个月大时对海马基因表达进行了RNA测序分析.
主要成果:
- 怀孕的小鼠表现出认知障碍,因胆缺乏症而加剧,并通过补充剂得到缓解.
- 产前胆含量对成年后期的认知功能和整体健康有显著影响.
- 通过RNA-Seq检测,发现对海马基因特征有持久的影响,胆缺乏可调节炎症基因,而补充剂可调节神经保护基因.
结论:
- 在怀孕期间补充胆可以为孕期和晚年母亲带来认知效益.
- 产前营养,特别是胆的可用性, 对大脑健康和认知功能有长期影响.
- 这项研究强调了胆在减轻女性认知衰退和痴呆风险方面的潜在作用.
相关概念视频
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
206
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
206
Cognitive Development During Adulthood
267
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
267
Role of Neurotransmitters in Memory
971
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
971
Alzheimer's Disease: Overview
666
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
666
Environmental Influences on Intelligence
413
Despite the strong genetic influence on traits like intelligence, environmental factors significantly shape outcomes. For example, while over 90% of height variation is due to genetic differences, environmental factors such as nutrition also have a notable impact. Similarly, for intelligence, changes in a child's surroundings can significantly alter their IQ. Research shows that enriched environments boost children's academic success and help them develop key cognitive skills. Children...
413
Alzheimer's Disease: Treatment
260
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
260


